E A Malykhina Selected Research

Stalevo

11/2008	Use of the new levodopa agent Stalevo (levodopa/carbidopa/entacapone) in the treatment of Parkinson's disease in out-patient clinical practice (the START-M open trial).
1/2007	[The study on the assessment of the new levodopa drug--stalevo (levodopa/carbidopa/entacapone), in treatment of Parkinson's disease in out-patient clinical practice (the results of the open START-M)].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

E A Malykhina Research Topics

Disease

4	Parkinson Disease (Parkinson's Disease) 01/2020 - 01/2006
2	Dyskinesias (Dyskinesia) 11/2008 - 01/2007
1	Prodromal Symptoms 01/2020
1	Synucleinopathies 01/2020
1	Dystonia (Limb Dystonia) 01/2010
1	Meige Syndrome 01/2010
1	Torticollis (Wryneck) 01/2010
1	Hypokinesia (Bradykinesia) 01/2006
1	Tremor (Tremors) 01/2006

Drug/Important Bio-Agent (IBA)

3	Levodopa (L Dopa)FDA LinkGeneric 01/2020 - 01/2007
2	Pharmaceutical PreparationsIBA 01/2010 - 01/2007
2	entacapone (Comtan)FDA Link 11/2008 - 01/2007
2	StalevoIBA 11/2008 - 01/2007
2	Carbidopa (Lodosyn)FDA LinkGeneric 11/2008 - 01/2007
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	SphingomyelinsIBA 01/2020
1	Tiapride HydrochlorideIBA 01/2010
1	Baclofen FDA LinkGeneric 01/2010
1	Clonazepam (Rivotril)FDA LinkGeneric 01/2010
1	pantogab (hopantenic acid)IBA 01/2010
1	Dopamine Receptors (Dopamine Receptor)IBA 11/2008
1	AntioxidantsIBA 01/2006
1	emoxypine succinateIBA 01/2006

Therapy/Procedure

2	Therapeutics 01/2007 - 01/2006